Out-of-pocket expenses and rationing of insulin and diabetes supplies: findings from the 2022 T1International cross-sectional web-based survey.
COVID-19
T1D
health equity
health policy
insulin
out-of-pocket expenses
rationing
type 1 diabetes
Journal
Frontiers in clinical diabetes and healthcare
ISSN: 2673-6616
Titre abrégé: Front Clin Diabetes Healthc
Pays: Switzerland
ID NLM: 9918266295306676
Informations de publication
Date de publication:
2024
2024
Historique:
received:
13
09
2023
accepted:
18
03
2024
medline:
7
5
2024
pubmed:
7
5
2024
entrez:
7
5
2024
Statut:
epublish
Résumé
Continue investigating Out-of-Pocket Expenses (OoPEs) and rationing of insulin and diabetes supplies, including impacts of the COVID-19 pandemic, for people with type 1 diabetes (T1D). A cross-sectional web-based survey was conducted in English and advertised by T1International's global network of patient advocates from May through September 2022. Participants provided monthly OoPEs and rationing frequency for insulin and supplies, impacts of the COVID-19 pandemic, and open-ended comments. In the seven most represented countries, mean monthly OoPEs were highest in the United States, followed by Panama, Canada, and India, and were much lower in the United Kingdom, Germany, and Sweden. OoPEs were highest for participants with partial healthcare coverage, followed by those with no healthcare coverage. The COVID-19 pandemic negatively impacted access and/or affordability of insulin and/or supplies for over half of participants. Globally, 19.5% reported insulin rationing and 36.6% reported rationing glucose testing supplies. Qualitative analysis of open-ended responses identified themes such as 'mental health impacts' and 'limits to life choices.' High OoPEs lead to rationing of insulin and supplies for many people with T1D globally. Healthcare systems improvements and price reductions of insulin and supplies are needed to ensure adequate, equitable access for all.
Identifiants
pubmed: 38711747
doi: 10.3389/fcdhc.2024.1293882
pmc: PMC11070566
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1293882Informations de copyright
Copyright © 2024 Souris, Pfiester, Thieffry, Chen, Braune, Kapil Bhargava, Samra, Gómez and O'Donnell.
Déclaration de conflit d'intérêts
EP is employed as the Executive Director of T1International. KS had a contract with T1International as the Global Advocacy Consultant. AT contracted with T1International to carry out quantitative analyses. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.